What makes a pluripotency reprogramming factor?

Area of Science:

• Cellular reprogramming
• Molecular biology
• Regenerative medicine

Background:

• Cellular reprogramming converts differentiated cells to a pluripotent state, crucial for regenerative medicine.
• The molecular mechanisms underlying this process, particularly what distinguishes pluripotency reprogramming factors (PRFs), remain incompletely understood.
• Current methods involve introducing transcription factor proteins to alter cell fate.

Purpose of the Study:

• To review the molecular characteristics of prominent PRFs (Sox2, Oct4, Klf4, Esrrb, Nr5a2, Nanog).
• To identify unique features that differentiate PRFs from homologous transcription factors.
• To explore the role of PRF cooperation in nuclear reprogramming.

Main Methods:

• Review of existing literature on the molecular makeup and DNA binding properties of key PRFs.
• Comparative analysis of DNA binding motifs between PRFs and non-pluripotency-inducing family members.
• Discussion of evidence supporting differential protein-protein interactions and composite DNA motifs in pluripotency enhancers.

Main Results:

• Consensus DNA binding motifs for most PRFs are highly conserved compared to non-pluripotency factors, suggesting individual sequence preference is not the primary differentiator.
• Variant composite DNA motifs in pluripotency enhancers facilitate differential assembly of PRF families through protein-protein interactions.
• Engineering a non-PRF (Sox17) into a PRF by modulating its cooperation with Oct4 demonstrates the importance of cooperative binding.

Conclusions:

• The cooperation of PRFs on specifically configured DNA motifs, mediated by protein-protein interactions, likely underlies the nuclear reprogramming process.
• Understanding these cooperative mechanisms is key to rationally engineering and optimizing PRFs.
• Enhanced PRF design can improve reprogramming efficiency for applications in regenerative medicine.